Agenda for Day 3 – Thursday, March 25, 2027Thursday, 25 March 2027 - EST/EDT (Eastern Daylight, GMT-4)

• Understand the complexity of the current insurance and policy landscape, including evolving payer requirements and regulatory changes that impact PA workflows

• Examine how technology like eBV, ePA and EMR integration can work together to streamline the prior authorization process and reduce approval timelines

• Uncover best practices for leveraging data, stakeholder collaboration and patient-centric workflows to simplify PA complexity, improve transparency and reduce access barriers in an evolving payer landscape

• Understand the critical importance of making distribution decisions at launch to avoid disrupting the provider and patient experience later on

• Explore the spectrum of distribution models and evaluate the pros, cons and strategic fit of each model based on your brand's goals, patient population and market dynamics

• Examine how hub interactions and service requirements differ across distribution models and how to design hub operations that align with your distribution strategy

• Discover what effective collaboration looks like between manufacturers and pharmacies, and between patient services and trade teams. Explore best practices for partnership, data sharing, business reviews and sustaining strong relationships over time

• Identify the metrics and strategies needed to evolve your distribution model post-launch, including how to evaluate performance, address data access barriers, streamline reporting processes and make informed decisions about when and how to expand or adjust your SP network

• Understand how manufacturers are helping patients recognize the value of the MP3 benefit structure and navigate the shift from traditional cost-sharing to the $2,000 out-of-pocket cap

• Explore what manufacturers can appropriately and compliantly do to support patients through the MP3 transition, including education, navigation assistance and financial support program redesign

• Learn how leading organizations are building patient communication strategies that empower self-advocacy while staying within regulatory boundaries as benefit changes continue to unfold

• Examine the operational and infrastructure adjustments required to support patients effectively under the new benefit design, including coordination with pharmacies, hubs and payer systems

• Examine how the industry is responding to massive Medicaid disenrollment following the Big Beautiful Bill implementation in January, including whether patient assistance programs are seeing enrollment surges as millions lose coverage and how manufacturers are adjusting uninsured support strategies

• Understand how benefit verification processes are evolving to account for Medicaid work requirements and time-limited eligibility, including whether hubs are adapting BV protocols to track qualification periods, verify ongoing eligibility and respond when patients lose jobs or fail to meet work requirements

• Explore the operational question of how much hand-holding hubs should provide to keep patients on Medicaid and how state-by-state variability in requirements is impacting hub workflows and resource allocation

• Discuss what additional services and support models manufacturers are deploying in response to state flexibility under BBB, and share real-time insights on what's working, what's failing and how organizations are balancing compliance, patient access and operational capacity in this rapidly shifting landscape

Join your peers for Access USA 2027's most candid session yet, alongside all ecosystem stakeholders. In this interactive closing conversation, join focused roundtables organized by vendor type – PAP providers, Hub services, AI solutions, specialty pharmacy partners and more.

Whether you're evaluating new partnerships, troubleshooting existing relationships or simply curious about what others are experiencing, this peer-to-peer exchange offers the unvarnished insights you won't find in any RFP response.

Come ready to listen, share and leave with actionable intelligence from those who've been in the trenches.